01 6Pfizer Canada Inc.
02 1Riches, McKenzie & Herbert LLP
01 32177576
02 32267186
03 12987272
01 1CELECOXIB
02 6Celecoxib
01 6Capsule
02 1SOLUTION
01 11936-05-27
02 32014-11-14
03 32017-10-14
Patent Expiration Date : 2017-10-14
Date Granted : 2002-05-14
Brand Name : CELEBREX
Patent Number : 2267186
Filing Date : 1997-10-14
Strength per Unit : 400mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-14
Date Granted : 2002-05-14
Patent Expiration Date : 2014-11-14
Date Granted : 1999-10-26
Brand Name : CELEBREX
Patent Number : 2177576
Filing Date : 1994-11-14
Strength per Unit : 400mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-11-14
Date Granted : 1999-10-26
Patent Expiration Date : 2017-10-14
Date Granted : 2002-05-14
Brand Name : CELEBREX
Patent Number : 2267186
Filing Date : 1997-10-14
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-14
Date Granted : 2002-05-14
Patent Expiration Date : 2014-11-14
Date Granted : 1999-10-26
Brand Name : CELEBREX
Patent Number : 2177576
Filing Date : 1994-11-14
Strength per Unit : 100mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-11-14
Date Granted : 1999-10-26
Patent Expiration Date : 2017-10-14
Date Granted : 2002-05-14
Brand Name : CELEBREX
Patent Number : 2267186
Filing Date : 1997-10-14
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-10-14
Date Granted : 2002-05-14
Patent Expiration Date : 2014-11-14
Date Granted : 1999-10-26
Brand Name : CELEBREX
Patent Number : 2177576
Filing Date : 1994-11-14
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-11-14
Date Granted : 1999-10-26
Patent Expiration Date : 1936-05-27
Date Granted : 2019-08-20
Brand Name : ELYXYB
Patent Number : 2987272
Filing Date : 2016-05-27
Strength per Unit : 120 mg / 4.8 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1936-05-27
Date Granted : 2019-08-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
